Keyphrases
Cardiac Hypertrophy
87%
Doxorubicin-induced Cardiotoxicity
86%
PARP Inhibitor (PARPi)
56%
Heart Failure
49%
Doxorubicin
44%
Isoproterenol
38%
Pathological Cardiac Hypertrophy
37%
JMJD3
33%
Sirtuin 1 (SIRT1)
33%
Apolipoprotein M
33%
Cardiomyocytes
32%
Overexpression
32%
Doxorubicin-induced Cardiomyopathy
25%
Phosphorylation
23%
Cardiomyopathy
22%
Neonatal Rat Cardiomyocytes
21%
Bromodomain-containing Protein 4 (BRD4)
20%
Cardiac Fibrosis
19%
Signaling Pathway
19%
Poly(ADP-ribose)
18%
Endothelial Nitric Oxide Synthase (eNOS)
18%
Jumonji Domain
18%
Acetylation
18%
NF-B
18%
Heart Failure with Preserved Ejection Fraction (HFpEF)
18%
Catenin
17%
Dickkopf-1 (DKK1)
16%
Citrate Cycle
16%
Bromodomain-containing Protein 2
16%
Sirtuin 6 (SIRT6)
16%
Lipoprotein Composition
16%
MHC Expression
16%
Pathological Myocardial Hypertrophy
16%
Anthracycline-induced Cardiotoxicity
16%
NFATc4
16%
Alternate-day Fasting
16%
Chrysophanol
16%
Sestrin2
16%
Obese Phenotype
16%
Endothelial Function
16%
Receptor 2
16%
Epigenetic Reader
16%
Anoxia-reoxygenation Injury
16%
Oxidative Stress
16%
Cellular Location
16%
Jumonji Domain-containing 3
16%
PARylation
16%
Nuclear Export
16%
Histone Demethylase
16%
Endothelial Senescence
16%
Pharmacology, Toxicology and Pharmaceutical Science
Cardiotoxicity
100%
Heart Ventricle Hypertrophy
83%
Doxorubicin
77%
Congestive Heart Failure
52%
Isoproterenol-Induced Cardiac Hypertrophy
35%
Nicotinamide Adenine Dinucleotide Adenosine Diphosphate Ribosyltransferase 1
33%
Apolipoprotein M
33%
Heart Muscle Fibrosis
21%
Isoprenaline
20%
Adenoviridae
19%
Heart Failure with Reduced Ejection Fraction
19%
Adenosine Diphosphate
18%
Catenin
17%
Anoxia
16%
Mammalian Target of Rapamycin
16%
Transcription Factors
16%
Endothelial Nitric Oxide Synthase
16%
Sirtuin 1
16%
High Density Lipoprotein
16%
Chrysophanic Acid
16%
Anthracycline
16%
Heme Oxygenase 1
16%
Silent Information Regulator Protein
16%
Kaempferol
16%
Secreted Frizzled Related Protein 1
16%
Comorbidity
16%
Dapagliflozin
16%
Histone
12%
Brain Natriuretic Peptide
10%
Sprague Dawley Rat
8%
3 Aminobenzamide
8%
Creatinine
7%
Albumin
7%
Myocardial Disease
7%
Growth Differentiation Factor 15
6%
Biological Marker
6%
Cardiovascular Disease
6%
Glycogen Synthase Kinase
5%
Lysine
5%
Histone H3
5%
Diseases
5%
Aortic Constriction
5%
Biochemistry, Genetics and Molecular Biology
Cardiac Muscle Cell
86%
Doxorubicin
61%
Isoprenaline
44%
Histone
35%
Demethylase
33%
Apolipoprotein
33%
Epigenetics
22%
BRD4
20%
Sphingosine-1-Phosphate
19%
Bromodomain
18%
Transcription Factors
18%
Programmed Cell Death
17%
Adenoviridae
16%
Citric Acid Cycle
16%
Poly ADP Ribose Polymerase
16%
SIRT6
16%
Acetylation
16%
Oxidative Stress
16%
Reoxygenation
16%
Sirtuin 1
16%
Catenin
16%
Adenosine Diphosphate
16%
Lipolysis
16%
BRD2
16%
Heme Oxygenase
16%
Kaempferol
16%
Sirtuin1
16%
Nitric Oxide Synthase
16%
Anthracycline
16%
STAT3
16%
Surface Area
14%
Photosynthetic Pigment
11%
Promoter Region
11%
Protein Expression
9%
Heart Function
9%
Gene Expression
9%
Growth Differentiation Factor
6%
Sprague Dawley Rat
5%
Lysine
5%
Histone Modification
5%
Heart Ejection Fraction
5%
Histone H3
5%
Glycogen Synthase Kinase
5%
Guide RNA
5%
Marker Gene
5%
Cell Maturation
5%
Lipotoxicity
5%
Arginine
5%
Wild Type
5%
Messenger RNA
5%
